ConductScience.org, home

Paper19946262

Selective FLT3 inhibitor FI-700 neutralizes Mcl-1 and enhances p53-mediated apoptosis in AML cells with activating mutations of FLT3 through Mcl-1/Noxa axis.

Kojima K and 8 others. Leukemia, 2010. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. Selective FLT3 inhibitor FI-700 neutralizes Mcl-1 and enhances p53-mediated apoptosis in AML cells with activating mutations of FLT3 through Mcl-1/Noxa axis. Papers, record 19946262. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19946262

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Selective FLT3 inhibitor FI-700 neutralizes Mcl-1 and enhances p53-mediated apoptosis in AML cells with activating mutations of FLT3 through Mcl-1/Noxa axis.
PubMed
Journal
Leukemia
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
0.61
iCite
Revised in PubMed
2026-10-10
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kojima KK
2Konopleva MM
3Tsao TT
4Andreeff MM
5Ishida HH
6Shiotsu YY
7Jin LL
8Tabe YY
9Nakakuma HH

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ApoptosisMajor topic
Leukemia, Myeloid, AcuteMajor topic
MutationMajor topic
Proto-Oncogene Proteins c-bcl-2Major topic
PyridinesMajor topic
PyrimidinesMajor topic
Tumor Suppressor Protein p53Major topic
fms-Like Tyrosine Kinase 3Major topic
Cell Line, Tumor
Doxorubicin
G1 Phase
Humans
Imidazoles
Myeloid Cell Leukemia Sequence 1 Protein
Piperazines
Proteasome Endopeptidase Complex
bcl-2-Associated X Protein

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P30CA016672NIH

Source NIH RePORTER

Download CSV of grants

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115902208An inhibitor of Bcl-2 family proteins induces regression of solid tumours.Nature2005https://conductscience.org/library/papers/15902208PubMed
216014563MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy.Blood2005https://conductscience.org/library/papers/16014563PubMed
312951584The role of FLT3 in haematopoietic malignancies.Nat Rev Cancer2003https://conductscience.org/library/papers/12951584PubMed
411090077Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways.Blood2000https://conductscience.org/library/papers/11090077PubMed
58946930Internal tandem duplication of the flt3 gene found in acute myeloid leukemia.Leukemia1996https://conductscience.org/library/papers/8946930PubMed
617554384BH3 mimetic ABT-737 neutralizes resistance to FLT3 inhibitor treatment mediated by FLT3-independent expression of BCL2 in primary AML blasts.Leukemia2007https://conductscience.org/library/papers/17554384PubMed
718230792Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.J Natl Cancer Inst2008https://conductscience.org/library/papers/18230792PubMed
815959528Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis.Leukemia2005https://conductscience.org/library/papers/15959528PubMed
91905840p53 mutations in human cancers.Science1991https://conductscience.org/library/papers/1905840PubMed
1017389404Structural insights into the degradation of Mcl-1 induced by BH3 domains.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17389404PubMed
1119144992A novel molecular mechanism of primary resistance to FLT3-kinase inhibitors in AML.Blood2009https://conductscience.org/library/papers/19144992PubMed
1210679322Rsk1 mediates a MEK-MAP kinase cell survival signal.Curr Biol2000https://conductscience.org/library/papers/10679322PubMed
1317097561The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.Cancer Cell2006https://conductscience.org/library/papers/17097561PubMed
1414704432In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.Science2004https://conductscience.org/library/papers/14704432PubMed
1516543145Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1.Mol Cell2006https://conductscience.org/library/papers/16543145PubMed
1612667443p53 has a direct apoptogenic role at the mitochondria.Mol Cell2003https://conductscience.org/library/papers/12667443PubMed
1717940205
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications.
Blood2008https://conductscience.org/library/papers/17940205PubMed
1815459012A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease.Blood2005https://conductscience.org/library/papers/15459012PubMed
1910713704Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line.Oncogene2000https://conductscience.org/library/papers/10713704PubMed
2014726387Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia.Blood2004https://conductscience.org/library/papers/14726387PubMed

See all 41 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
31127149Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia.Leukemia2019https://conductscience.org/library/papers/31127149PubMed
28727820Active hexose-correlated compound enhances extrinsic-pathway-mediated apoptosis of Acute Myeloid Leukemic cells.PLoS One2017https://conductscience.org/library/papers/28727820PubMed
28530640Genetic regulation of the RUNX transcription factor family has antitumor effects.J Clin Invest2017https://conductscience.org/library/papers/28530640PubMed
28505595Epigenetic drug combination induces remission in mouse xenograft models of pediatric acute myeloid leukemia.Leuk Res2017https://conductscience.org/library/papers/28505595PubMed
28286924Treatment of Relapsed/Refractory Acute Myeloid Leukemia.Curr Treat Options Oncol2017https://conductscience.org/library/papers/28286924PubMed
28211885The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells.Blood Cancer J2017https://conductscience.org/library/papers/28211885PubMed
26459177Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia.Clin Cancer Res2016https://conductscience.org/library/papers/26459177PubMed
26375587Mitochondrial Profiling of Acute Myeloid Leukemia in the Assessment of Response to Apoptosis Modulating Drugs.PLoS One2015https://conductscience.org/library/papers/26375587PubMed
25231999Targeting FLT3 to treat leukemia.Expert Opin Ther Targets2015https://conductscience.org/library/papers/25231999PubMed
23955073PI3K inhibitor GDC-0941 enhances apoptotic effects of BH-3 mimetic ABT-737 in AML cells in the hypoxic bone marrow microenvironment.J Mol Med (Berl)2013https://conductscience.org/library/papers/23955073PubMed
23531342Targeting p53 by small molecules in hematological malignancies.J Hematol Oncol2013https://conductscience.org/library/papers/23531342PubMed
23036488Mechanisms of apoptosis induction by simultaneous inhibition of PI3K and FLT3-ITD in AML cells in the hypoxic bone marrow microenvironment.Cancer Lett2013https://conductscience.org/library/papers/23036488PubMed
22797419FLT3 inhibition: a moving and evolving target in acute myeloid leukaemia.Leukemia2013https://conductscience.org/library/papers/22797419PubMed
21868571p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1α-mediated down-regulation of CXCL12.Blood2011https://conductscience.org/library/papers/21868571PubMed
21471285The multitargeted receptor tyrosine kinase inhibitor linifanib (ABT-869) induces apoptosis through an Akt and glycogen synthase kinase 3β-dependent pathway.Mol Cancer Ther2011https://conductscience.org/library/papers/21471285PubMed
20952518Phase I study of sorafenib in patients with refractory or relapsed acute leukemias.Haematologica2011https://conductscience.org/library/papers/20952518PubMed
20587003Clinical proteomics of myeloid leukemia.Genome Med2010https://conductscience.org/library/papers/20587003PubMed
20404136Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia.Blood2010https://conductscience.org/library/papers/20404136PubMed
20013323p53 is critical for the Aurora B kinase inhibitor-mediated apoptosis in acute myelogenous leukemia cells.Int J Hematol2010https://conductscience.org/library/papers/20013323PubMed

Download CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BAX581PubTator's text mininghttps://conductscience.org/library/genes/581NCBI Gene
BCL2L1110018PubTator's text mininghttps://conductscience.org/library/genes/10018NCBI Gene
FLT32322PubTator's text mininghttps://conductscience.org/library/genes/2322NCBI Gene
MCL14170PubTator's text mininghttps://conductscience.org/library/genes/4170NCBI Gene
MDM24193PubTator's text mininghttps://conductscience.org/library/genes/4193NCBI Gene
PMAIP15366PubTator's text mininghttps://conductscience.org/library/genes/5366NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19946262

GET https://conductscience.org/api/papers/v1/19946262/references?page=2